Skip to content
Study details
Enrolling now

Sana Device for Chronic Pain

Icahn School of Medicine at Mount Sinai
NCT IDNCT06655844ClinicalTrials.gov data as of Apr 2026
Target enrollment

30

Study length

about 1.5 years

Ages

18+

Locations

1 site in NY

What this study is about

Researchers are testing a device called Sana Pain Reliever (Sana PR) to see if it helps reduce chronic pain in people who have had Lyme disease and are still experiencing pain. The Sana PR is a wearable device that uses light pulses, tones, and HRV sensors to provide treatment. The trial will last for 14 weeks.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Sana Pain Reliever
  • 2.Use Sham SPR

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Neuropathic Pain Symptom Inventory

Secondary: Beck Depression Inventory (BDI), General Anxiety Disorder 7-item questionnaire (GAD-7), Pittsburgh Sleep Quality Index (PSQI), Visual analogue scale (VAS)- Pain, Visual analogue scale (VAS)- Sleep